TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION IN RUXOLITINIB-TREATED PATIENTS WITH MYELOFIBROSIS WITH AND WITHOUT ANEMIA: A REAL-WORLD ANALYSIS

被引：0
|
作者：
Liu, T. [1 ]
Fillbrunn, M. [2 ]
Chen, J. [2 ]
Sajeev, G. [2 ]
Zhang, S. [3 ]
Signorovitch, J. [2 ]
机构：
[1] GSK plc, Philadelphia, PA USA
[2] Anal Grp Inc, Boston, MA USA
[3] GSK, Philadelphia, PA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE407
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [31] Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource Utilization
    Boskovic, Dusica Hadzi
    Liang, Shuting
    Parab, Purva
    Wiggins, Emily
    Liberman, Joshua N.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 487 - 498
  • [32] Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA
    Laliberte, Francois
    Raut, Monika
    Yang, Xiaoqin
    Germain, Guillaume
    Nahar, Akash
    Desai, Kaushal D.
    MacKnight, Sean D.
    Sen, Shuvayu S.
    Duh, Mei Sheng
    TARGETED ONCOLOGY, 2021, 16 (01) : 85 - 94
  • [33] CLINICAL CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION IN A REAL-WORLD COHORT OF PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB
    Chiorean, Michael V.
    Sharma, Puza P.
    Salese, Leonardo
    Gruben, David
    Woolcott, John
    Khan, Nabeel
    GASTROENTEROLOGY, 2021, 160 (06) : S229 - S230
  • [34] Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA
    François Laliberté
    Monika Raut
    Xiaoqin Yang
    Guillaume Germain
    Akash Nahar
    Kaushal D. Desai
    Sean D. MacKnight
    Shuvayu S. Sen
    Mei Sheng Duh
    Targeted Oncology, 2021, 16 : 85 - 94
  • [35] Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes
    Gerds, Aaron T.
    Yu, Jingbo
    Scherber, Robyn M.
    Paranagama, Dilan
    Kish, Jonathan K.
    Visaria, Jay
    Singhal, Mukul
    Verstovsek, Srdan
    Pemmaraju, Naveen
    ACTA HAEMATOLOGICA, 2022, 145 (04) : 448 - 452
  • [36] Ruxolitinib for myelofibrosis in elderly non-transplant patients: healthcare resource utilization and costs
    Gerds, Aaron T. T.
    Yu, Jingbo
    Shah, Anne
    Xi, Ann
    Kumar, Shambhavi
    Scherber, Robyn
    Parasuraman, Shreekant
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 843 - 849
  • [37] Real-World Treatment Patterns and Healthcare Resource Utilization in Patients with Waldenstrom Macroglobulinemia Initiating First-Line Treatment with Ibrutinib or Zanubrutinib
    Paludo, Jonas
    Sarosiek, Shayna R.
    von Keudell, Gottfried R.
    Salkar, Monika
    Zhou, Summera
    Kim, Sonia
    Cheng, Ning
    Pacia, Michelle
    Karve, Sudeep
    Castillo, Jorge J.
    BLOOD, 2023, 142
  • [38] Patient Characteristics, Treatment Patterns, and Health Outcomes in a Real-World Population of Patients with Myelofibrosis Treated with Fedratinib
    Passamonti, Francesco
    Parikh, Rohan C.
    Korgaonkar, Siddhi
    Chevli, Manoj
    Slaff, Samantha
    Rombi, Julien
    Adeyemi, Basirat
    Davis, Keith L.
    Yucel, Aylin
    BLOOD, 2023, 142
  • [39] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION OF PATIENTS WITH METASTATIC BREAST CANCER: A RETROSPECTIVE COHORT ANALYSIS
    Hanson, K.
    Cha-Silva, A.
    Hull, M.
    DeKoven, M.
    Anupindi, V. R.
    Doshi, R.
    Rocque, G.
    VALUE IN HEALTH, 2023, 26 (06) : S110 - S110
  • [40] End-of-life healthcare resource utilization and costs in patients with PAH: a real-world analysis
    Weiss, Tracey
    Ramey, Dena Rosen
    Ngan Pham
    Shaikh, Nazneen
    Tian, Dajun
    Zhao, Xiaohui
    Near, Aimee
    Nathan, Steven
    Lautsch, Dominik
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345